Indication
Basal cell carcinoma of skin
Basal cell carcinoma of skin is a common, slow-growing cutaneous malignancy arising from the pluripotential epithelial cells within the basal layer of the epidermis and hair follicles. Read more about Basal cell carcinoma of skin
5 drugs 5 manufacturers
Drugs that treat it
Common Basal cell carcinoma of skin therapies.
LIBTAYO (cemiplimab-rwlc)
ERIVEDGE (vismodegib)
ODOMZO (sonidegib phosphate)
ODOMZO (sonidegib phosphate)
ODOMZO (sonidegib phosphate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonBasal cell carcinoma of skin is a common, slow-growing cutaneous malignancy arising from the pluripotential epithelial cells within the basal layer of the epidermis and hair follicles.
It predominantly affects the integumentary system of older adults and fair-skinned individuals, most frequently presenting in chronologically sun-damaged anatomical areas such as the head, neck, and extremities.
Pathophysiologically driven by cumulative ultraviolet radiation exposure and aberrant Hedgehog signaling pathway activation, lesions classically manifest as pearly, translucent papules or plaques with telangiectasias, rolled borders, or central ulceration.
Although distant metastasis is rare, the condition can cause substantial local tissue invasion and destruction if left untreated.
- cancer.gov
Basal cell carcinoma of skin is a common, slow-growing cutaneous malignancy arising from the pluripotential epithelial cells within the basal layer of the epidermis and hair follicles It predominantly affects the integumentary system of older adults and fair-skinned individuals, most frequently presenting in chronologically sun-damaged anatomical areas such as the head, neck, and extremities Pathophysiologically driven by cumulative ultraviolet radiation exposure and aberrant Hedgehog signaling ...
- cancer.gov
Basal cell carcinoma of skin is a common, slow-growing cutaneous malignancy arising from the pluripotential epithelial cells within the basal layer of the epidermis and hair follicles
- cancer.gov
It predominantly affects the integumentary system of older adults and fair-skinned individuals, most frequently presenting in chronologically sun-damaged anatomical areas such as the head, neck, and extremities Pathophysiologically driven by cumulative ultraviolet radiation exposure and aberrant Hedgehog signaling pathway activation, lesions classically manifest as pearly, translucent papules or plaques with telangiectasias, rolled borders, or central ulceration
- cancer.gov
Pathophysiologically driven by cumulative ultraviolet radiation exposure and aberrant Hedgehog signaling pathway activation, lesions classically manifest as pearly, translucent papules or plaques with telangiectasias, rolled borders, or central ulceration
Personalize your experience
Follow Basal cell carcinoma of skin and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.